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Abstract
Background: Limited data exists on the durability and occlusion rate of treating 
extracranial cervical internal carotid artery pseudoaneurysms using the pipeline 
embolization device (PED) flow‑diverting stent.
Methods: Three patients presenting with dissecting cervical internal carotid artery 
pseudoaneurysms were treated with the PED as the sole treatment modality.
Results: In all three patients, successful aneurysmal occlusion and parent vessel 
reconstruction occurred on immediate angiography and continued on 6‑month 
follow‑up. No immediate or delayed complications were seen, and all patients 
remained neurologically intact.
Conclusion: Complete aneurysmal occlusion and long‑term angiographic 
occlusion can occur after PED treatment of cervical carotid pseudoaneurysms. In 
select patients, the PED can be a suitable primary treatment modality with good 
neurological outcome for cervical carotid pseudoaneurysms.
Key Words: Cervical carotid, dissection, pipeline embolization device, 
pseudoaneursym
INTRODUCTION
Cervical internal carotid artery dissections and 
pseudoaneurysms are not uncommon. Recent studies have 
demonstrated a prevalence of blunt cervical vascular injury 
at 1.2–1.6% of trauma patients and 2.7% of multisystem 
trauma patients.[35,36] The average annual incidence of 
spontaneous and iatrogenic injuries to the carotid and 
vertebral arteries has been reported at 2.9 per 100,000.[35,36]
The majority of dissections, Denver Grades 1 and 2, heal 
with medical therapy and less than 10% progress to a 
pseudoaneurysm.[4,5] Grade II lesions improved to grade I 
lesions in 13.5% of the patients whereas 45.9% progressed 
to a worse grade. The majority of pseudoaneurysms persist, 
with only 3% of Grade 3 lesions healing with medical 
therapy and another 3% progress to complete vessel 
occlusion. Studies with early follow‑up imaging show that 
over 90% of pseudoaneurysms persisted at 1 week.[5,6] In a 
study with 6‑month follow up, 72% of grade I lesions and 
33% of grade II lesions healed. Edwards et al. reported 
that, with medical therapy, only 10% of pseudoaneurysms 
healed whereas 40% progressed.[16]
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The recent advances in endovascular technology have 
shifted treatment paradigms away from microsurgical 
techniques and towards endovascular treatment of 
dissecting carotid pseudoaneurysms.[26,32,33,36,39] A few small 
retrospective case series have demonstrated the success of 
vascular stents and coils in treating these lesions.[3,8,17,33,38] 
Flow‑diverting devices such as the pipeline embolization 
device (PED; ev3‑Covidien, Irvine, CA, USA) represent 
a changing paradigm in the treatment of intracranial 
aneurysms. While specifically designed for use on wide 
necked unruptured large and complex aneurysms, the PED 
has found success in treating internal carotid artery and 
vertebral artery dissecting pseudoaneurysms.[1,19,28,30,34,37] 
The majority of the current literature supporting PED 
success has been centered on treating the intracranial 
segment of these vessels.
The application of the PED on cervical carotid 
pseudoaneurysms is limited. To date, there has only 
been one published study applying the PED to treat 
high cervical carotid pseudoaneurysms.[34] We present 
our experience using the PED as the sole treatment 
modality in three patients with high cervical carotid 
pseudoaneurysms, and briefly discuss the technical and 
perioperative management of these patients.
CASE REPORTS
Three patients with Denver Grade 3, dissecting cervical 
carotid artery pseudoaneurysms were treated at our 
institution using the PED [Table 1]. A pretreatment 
computed tomography (CT) of the head and CT 
angiogram of the head and neck were performed 
on all patients. All cases demonstrated a dissecting 
pseudoaneurysm of the extracranial cervical internal 
carotid artery segment. The clinical status with respect 
to presenting symptoms and Glasgow Coma Score (GCS) 
was recorded prior to endovascular treatment.
All patients were loaded on aspirin and clopidogrel 24 
hours prior to PED placement with platelet reactivity 
testing performed to confirm adequate platelet 
inhibition. At the beginning of each case, a baseline 
activated clotting time (ACT) was obtained, and 
a weight based intraoperative bolus of intravenous 
heparin was given after femoral artery access to 
maintain an ACT of >200 seconds throughout the 
procedure. All interventions were performed in a biplanar 
fluoroscopic angiography suite under general anesthesia 
using intraoperative monitoring (somatosensory 
evoked potentials, motor evoked potentials, and 
electroencephalography).
The PED (ev3‑Covidien) was used in all cases as the 
only device. Conventional and three‑dimensional (3D) 
angiographic studies were performed and working angle 
projections for PED placement were acquired at high 
magnification of the cervical carotid artery. In all patients, 
consecutive PED stents were placed in a telescoping 
fashion, distal to proximal, to cover the pseudoaneurysm.
Immediately after the treatment, all patients were 
extubated and observed in the intensive care unit for 
24 hours with hourly neurological examinations. All 
patients were verified to be aspirin and clopidogrel 
responders and were continued on daily 325 mg aspirin 
and 75 mg clopidogrel.
The angiographic features of the pseudoaneurysms and 
outcomes with respect to clinical and radiographic images 
of the patients are reviewed. With radiographic outcome, 
immediate and 6‑month follow up angiograms of the 
patients were reviewed to examine contrast stagnation, 
occlusion of the pseudoaneurysm, and in‑stent patency 
following PED deployment.
Case 1
Patient 1, in the second decade of life, presented intubated 
with multisystem trauma from a motor vehicle accident; 
GCS 5T and an injury severity score (ISS) of 41/75. 
Initial CT angiogram of the head and neck demonstrated 
grade I mild focal narrowing of the right cervical carotid 
artery at the level of C1‑2. A repeat CT angiogram 1 week 
later showed stability of the diseased carotid segment 
whereas a CT angiogram at 3 weeks demonstrated 
interval development of a 6.5 mm × 14 mm dissecting 
pseudoaneurysm of the right cervical internal carotid 
artery at the C1‑2 level [Figure 1a]. Cerebral angiography 
was performed [Figure 1b and c] and the aneurysm was 
treated with 4 telescoping PEDs (two 5.0 mm × 20 mm, 
5.0 × 18 mm, 4.25 mm × 20 mm). Final angiograms 
showed good wall apposition of the PEDs and improved 
vessel flow and caliber [Figure 1d and e].
Table 1: Demographic and clinical characteristics, treatments, and outcomes in three patients
Patient Age (years), sex Etiology, Presentation Side Aneurysm 
size
Location Treatment 6‑month Follow‑up
1 20s, M Iatrogenic injury, polytrauma Right 2.0×1.0 mm Distal 
cervical
Pipeline×4 Complete occlusion
2 40s, F Iatrogenic injury, Horner’s syndrome Right 5.0×3.5 mm Distal 
cervical
Pipeline×2 Complete occlusion
3 20s, M Iatrogenic injury, polytrauma Right 15.0×10 mm Distal 
cervical
Pipeline×4 Complete occlusion
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Case 2
Patient 2, in the fourth decade of life, presented with clinical 
symptoms consistent with recurrent Horner’s syndrome 
after recovering from an upper respiratory infection. CT 
angiogram of the neck demonstrated an enlarging medially 
projecting 3.3 mm × 6.6 mm pseudoaneurysm of the 
right cervical internal carotid artery compared to the CT 
angiogram 3 years ago [Figure 2a]. Cerebral angiography 
confirmed the pseudoaneurysm [Figure 2b]. Two telescoping 
PEDs, 4.5 mm × 16 mm and a 5.0 mm × 16 mm, were 
used [Figure 2c].
Case 3
Patient 3, in the second decade of life, presented 
intubated with multisystem trauma from a motor vehicle 
accident; GCS 6T with extensive extremity fractures and 
lung injuries with an ISS of 48/75. Initial CT angiogram 
of the head and neck demonstrated a dissection flap with 
associated pseudoaneurysm of the right distal cervical 
internal carotid artery. Follow up CTA showed that the 
pseudoaneurysm enlarged [Figure 3a]. Four telescoping 
PEDs, 5.0 mm × 20 mm, were used [Figures 3b‑e].
PEDs were successfully placed in all three patients. In 
patients 1 and 3, overlapping PEDs were deployed. In 
patient 2, a second PED was needed after foreshortening 
of the first PED was observed. At the completion of the 
cases, increased intra‑aneurysmal contrast stagnation, 
improved vessel caliber, and normal intracranial vascular 
flow were seen on the final angiographic runs.
No neurological deficits or access site complications were 
observed. Patients 1 and 3 underwent multiple surgeries 
to repair severe facial and lower extremity fractures and 
remained neurologically intact at the time of discharge. 
Patient 2 continued to exhibit Horner’s syndrome at the 
time of discharge. All patients were discharged on daily 
aspirin and clopidogrel therapy.
Patient 1 returned within 1 week of discharge with 
transient left‑sided weakness. A CT head confirmed no 
delayed intracerebral hemorrhage, and a CT angiogram 
demonstrated patent intracranial vessels without in‑stent 
thrombosis. Magnetic resonance imaging of the brain 
showed no restricted diffusion changes. The patient was 
observed and discharged after complete resolution of his 
symptoms.
All patients remained neurologically intact (modified 
rankin scale = 0) at 6‑month follow up visit. Complete 
aneurysm occlusion and normal vessel caliber were seen 
on repeat angiography at the time [Figures 1f, 2d and 3f].
DISCUSSION
The majority of extracranial dissections, Denver grade 1 
and 2, heal with medical therapy alone, however, 
medical therapy is not as effective for pseudoaneurysms, 
Denver Grade 3.[4,6,16] Endovascular treatment of 
Grades 1 and 2 dissections is usually reserved for 
patients who fail medical therapy or who have symptoms 
from perfusion abnormalities. Endovascular treatment 
of pseudoaneurysms is recommended for those with 
enlarging pseudoaneurysms or those with embolic events 
despite medical therapy. Endovascular constructs offer 
several advantages, they restore the vessel lumen of the 
dissected segment, and provide a support scaffold for 
endothelialization and healing.[13,14,23] Moreover, depending 
on the porosity of the stent or construct, it reduces or 
Figure 2: (a) CTA of the head and neck demonstrates a 
pseudoaneurysm of the high cervical carotid artery. (b) Oblique 
view DSA before deployment of the PED shows a cervical carotid 
pseudoaneurysm. (c) Immediate and (d) 6‑month follow‑up DSA 
show decreased aneurysm filling, intra‑aneurysmal stasis, and 
complete occlusion of the pseudoaneurysm
a b
c dFigure 1: (a) CT angiogram (CTA) of the head and neck showing 
the diseased cervical carotid artery segment with pseudoaneurysm 
formation, dissection flap, and intervening arterial stenosis. 
(b) Lateral and (c) AP view digital subtraction angiograms (DSA) 
before deployment of the pipeline embolization device (PED) 
show a high cervical carotid pseudoaneurysm and vessel stenosis. 
(d) Immediate DSA following PED placement shows improved 
vessel caliber. (e) CTA post‑treatment demonstrating the span of 
the telescoping PED stents and immediate improvement in vessel 
caliber and aneurysm occlusion. (f) DSA at 6‑month follow‑up 
showing the pseudoaneurysm remaining occluded and normal 
contour of the cervical carotid artery
a b c
d e f
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diverts blood flow from the aneurysm sac while avoiding 
manipulation of the aneurysm dome and fragile wall.
Treatment of extracranial carotid artery 
pseudoaneurysms
Stent‑assisted coil embolization and endovascular 
stent reconstruction are effective means of treating 
internal carotid pseudoaneurysms. Bush et al. reported 
their success with stent‑assisted coiling of five 
pseudoaneurysms with four of five stent constructs 
remaining patent on follow‑up.[8]
Stenting alone is an alternative treatment. A study 
by Yi et al. demonstrated a 100% occlusion rate of ten 
carotid pseudoaneurysms treated with self‑expanding or 
balloon‑expandable covered stents without recanalization 
at 6 months.[38] Balloon‑expandable stents have a greater 
metal surface area and radial force to promote intimal 
healing, however, are less flexible and can lead to crimping 
of the stent during neck flexion or extension.[2,22] The 
higher radial force can cause trauma to the fragile wall 
upon stent deployment and may not be ideal for use on 
high cervical pseudoaneurysms.
The ideal device for the craniocervical junction would 
be self‑expanding and flexible enough to adapt to 
arterial walls, atraumatic to the vessel wall upon 
deployment, and have enough radial force to treat the 
diseased segment. Pham et al. conducted a systematic 
review and found that 15 of 28 studies reported the 
successful use of the self‑expandable Wall stent (Stryker 
Neurovascular, Fremont, CA, USA) and another four 
studies with the self‑expandable SMART stent (Cordis, 
Miami, Fl, USA) in treating high cervical carotid 
pseudoaneurysms.[31] The Neuroform stent’s (Boston 
Scientific Corporation, Fremont, CA, USA) thin and 
open cell frame design leads to a relatively low metal 
surface area and may be suboptimal in covering the 
porous inflow zone to a pseudoaneurysm and being 
used as reliable stand‑alone therapy. However, in two 
studies, the Neuroform stent was used with success in 
distal cervical dissections.[2,17] Coldwell et al. described 
14 traumatic carotid artery pseudoaneurysms treated 
with self‑expanding bare metal stents with all aneurysms 
remaining occluded at 6 months.[13] Recently, Ansari 
et al. used a Neuroform self‑expanding stent to treat nine 
carotid pseudoaneurysms with complete or near‑complete 
occlusion of the aneurysms.[2]
Current applications of the pipeline embolization 
device for cervical and intracranial dissections
The PED is a microcatheter delivered self‑expanding 
stent‑like construct that is very effective for treating 
intracranial fusiform, large, or wide‑necked aneurysms. 
The PED offers the advantage of being used as a 
stand‑alone device with immediate flow diversion and 
intra‑aneurysmal thrombosis.
The application of the PED on treating dissecting 
pseudoaneurysms has mainly focused on the 
intracranial circulation.[11,14,21,27,28,30] De Barros Faria et al. 
demonstrated the successful application of the PED 
alone on 21 dissecting pseudoaneurysms of the posterior 
circulation, in which 87.5% were occluded at 3‑month 
follow‑up.[15] Similarly, Narata et al. and Yeung et al. both 
reported complete occlusion of all ruptured dissecting 
vertebral aneurysms treated in their respective case series 
with the PED stent alone.[28,37] A few case reports have 
been reported in the literature highlighting the use of the 
PED on anterior circulation. Amenta et al. was the first to 
highlight the successful use of the PED in the treatment 
of cavernous carotid pseudoaneurysm incurred during 
transphenoidal pituitary tumor resection.[1] Subsequently, 
Nerva et al. recently discussed their success with the PED 
in treating two iatrogenic carotid pseudoaneurysms of the 
cavernous segment.[30]
The PED has several properties that make it suitable 
for treating extracranial cervical dissections. Its flexible 
self‑expanding design combined with the advantage 
of using a smaller guide and microcatheter platform 
allows for greater maneuverability through tortuous 
and narrowed vessel segments at the skull base. In 
their series of 11 patients with 13 extracranial carotid 
dissections, Brzezicki et al. demonstrated immediate 
complete revascularization in 91% of the vessels 
and complete occlusion of 50% of the associated 
pseudoaneurysms.[7] Follow‑up imaging of nine vessels 
at 9 months demonstrated good durability without 
significant in‑stent stenosis or migration of the PED 
construct. Park et al. described one patient who was 
treated with a PED for an iatrogenic cervical carotid 
Figure 3: (a) CTA of the head and neck demonstrates a 
pseudoaneurysm of the high cervical carotid artery. (b) Lateral and 
(c) AP view DSA before deployment of the PED shows a cervical 
carotid pseudoaneurysm. (d) Immediate DSA shows decreased 
aneurysm filling. (e) CTA post‑treatment demonstrating the PED 
stents. (f) DSA at 6‑month follow‑up showing the pseudoaneurysm 




Surgical Neurology International 2017, 8:3 http://www.surgicalneurologyint.com/content/8/1/3
dissection, which on follow‑up angiogram 2 days later 
showed complete occlusion.[31] Cohen et al. showed good 
long‑term durability at 18 months in their cohort of three 
patients treated with the PED for cervical vertebral artery 
dissections.[12] Fischer et al. described their experience 
with the PED in treating 12 cervical carotid lesions 
in their larger cohort of 69 lesions.[20] To date there is 
little data on the details of occlusion rates or long‑term 
durability with this approach.
Technical considerations in choosing a stand‑alone 
construct
Stent reconstruction in the distal cervical carotid 
artery may be challenging because of the tortuosity of 
this segment and the changing diameter and mobility 
of the cervical carotid artery with head movements. 
There has been limited use of the PED on extracranial 
cervical carotid pseudoaneurysms. In our three cases, 
conventional self‑expanding carotid or smaller biliary 
stents would have necessitated larger constructs being 
navigated through the dissected segment and into 
the petrous carotid segment. The PED’s flexible and 
self‑expanding design combined with the advantage 
of using a smaller guide and microcatheter platform 
allows for greater maneuverability through tortuous and 
narrowed vessel segments.[25,29,30,33]
The length and diameter of the diseased segment as well 
as the adjacent normal segments are carefully evaluated 
when choosing the appropriate stent or flow diverter 
construct. Stents such as the Neuroform and Enterprise 
(Codman Neurovascular, Raynham, MA, USA) have a 
maximum diameter of 4.5 mm, making them less suitable 
in the larger mid‑cervical and proximal‑cervical internal 
carotid artery. The PED is available from 2.5 to 5.0 mm 
with 0.25 mm increments and lengths of 10 to 35 mm. 
The 5.0 mm PED expands to 5.25 mm.[29]
It is important to consider that oversizing the PED can 
lead to elongation of the device with poor coverage of the 
lesion and a decrease in flow diversion. Undersizing the 
device may result in poor wall apposition, an endoleak, as 
well as a potential risk of stent migration. Selection of a 
suboptimal PED and potential stent foreshortening and 
delayed migration of the device in both intracranial and 
extracranial disease has been reported.[9,10,18,24] Rahal et al. 
used the PED in conjunction with an anchoring Solitaire 
stent to treat two patients with shallow wide‑necked 
cervical pseudoaneurysms in the hopes of avoiding stent 
migration and foreshortening.[34] They deployed a Solitaire 
stent (ev3 – Covidien, Irvine, CA, USA) in a concentric 
manner to anchor their PEDs, but still experienced 
delayed foreshortening of the PED on follow‑up imaging. 
In all three of our patients, we placed multiple stents 
in tandem and ensured that the stent constructs were 
long enough to guarantee coverage of the entire lesion 
with sufficient overlap of the normal proximal and distal 
adjacent segments. Six‑month follow‑up angiograms 
showed intact coverage of the aneurysm neck, good wall 
apposition of the PED, and no evidence of aneurysm 
recurrence in all three patients.
The effectiveness of flow diversion may vary with the 
amount of metal coverage. The high porosity of currently 
available stents limits the ability to change inflow 
within an aneurysm. The PED was specifically designed 
to address this issue with the goal of promoting more 
effective flow diversion. The PED achieves this because of 
its low porosity and 30–35% surface metal area coverage, 
which is more than other stents such as the Xpert Biliary 
Stent (Abbott Vascular, Santa Clara, CA, USA) (20%) and 
Neuroform (9%) and Enterprise Stents (7%) [Table 2]. As 
a comparison, this results in a flow reduction of 37% and 
55% for single and overlapping PED vs. a flow reduction 
of 24% in the Neuroform Stent.[2,17]
Lastly, while the PED offers certain advantages over 
other stents available in the market, it is associated 
with adverse cost considerations ($12500 per PED) and 
may not be ideal for each patient and each institution, 
especially if multiple PEDs will be placed.
CONCLUSIONS
The application of flow diverters in treating cervical 
carotid pseudoaneurysms is limited. Our study highlights 
the use of the PED as the sole modality for the treatment 
of cervical carotid artery dissecting pseudoaneurysms. 
Although small, our series demonstrates the successful 
use of the PED as a primary endovascular modality with 
excellent 6‑month radiographic and clinical outcomes.
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